vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $47.3M, roughly 1.3× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -70.9%, a 72.1% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 8.1%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-1.8M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
CTKB vs MAMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $47.3M |
| Net Profit | $-44.1M | $540.0K |
| Gross Margin | 52.9% | 23.6% |
| Operating Margin | -9.0% | 1.7% |
| Net Margin | -70.9% | 1.1% |
| Revenue YoY | 8.1% | 50.0% |
| Net Profit YoY | -557.1% | 31.7% |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $47.3M | ||
| Q3 25 | $52.3M | $35.2M | ||
| Q2 25 | $45.6M | $35.3M | ||
| Q1 25 | $41.5M | $33.6M | ||
| Q4 24 | $57.5M | $31.5M | ||
| Q3 24 | $51.5M | $28.4M | ||
| Q2 24 | $46.6M | $29.8M | ||
| Q1 24 | $44.9M | $26.7M |
| Q4 25 | $-44.1M | $540.0K | ||
| Q3 25 | $-5.5M | $1.3M | ||
| Q2 25 | $-5.6M | $1.2M | ||
| Q1 25 | $-11.4M | $1.6M | ||
| Q4 24 | $9.6M | $410.0K | ||
| Q3 24 | $941.0K | $1.1M | ||
| Q2 24 | $-10.4M | $553.0K | ||
| Q1 24 | $-6.2M | $1.4M |
| Q4 25 | 52.9% | 23.6% | ||
| Q3 25 | 52.7% | 24.9% | ||
| Q2 25 | 52.3% | 26.1% | ||
| Q1 25 | 48.6% | 27.0% | ||
| Q4 24 | 58.5% | 22.6% | ||
| Q3 24 | 56.3% | 24.2% | ||
| Q2 24 | 54.6% | 25.0% | ||
| Q1 24 | 51.3% | 29.3% |
| Q4 25 | -9.0% | 1.7% | ||
| Q3 25 | -17.6% | 4.8% | ||
| Q2 25 | -23.3% | 4.5% | ||
| Q1 25 | -36.1% | 5.7% | ||
| Q4 24 | 5.2% | 1.8% | ||
| Q3 24 | -8.2% | 5.7% | ||
| Q2 24 | -18.3% | 2.6% | ||
| Q1 24 | -23.9% | 7.4% |
| Q4 25 | -70.9% | 1.1% | ||
| Q3 25 | -10.5% | 3.6% | ||
| Q2 25 | -12.2% | 3.5% | ||
| Q1 25 | -27.5% | 4.8% | ||
| Q4 24 | 16.8% | 1.3% | ||
| Q3 24 | 1.8% | 4.0% | ||
| Q2 24 | -22.4% | 1.9% | ||
| Q1 24 | -13.8% | 5.3% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $18.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $49.6M |
| Total Assets | $461.5M | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $18.1M | ||
| Q3 25 | $93.3M | $9.4M | ||
| Q2 25 | $75.5M | $12.0M | ||
| Q1 25 | $95.3M | $7.2M | ||
| Q4 24 | $98.7M | $9.3M | ||
| Q3 24 | $162.3M | $7.4M | ||
| Q2 24 | $177.9M | $13.0M | ||
| Q1 24 | $168.8M | $11.0M |
| Q4 25 | $341.7M | $49.6M | ||
| Q3 25 | $378.6M | $29.6M | ||
| Q2 25 | $377.6M | $26.4M | ||
| Q1 25 | $379.6M | $24.9M | ||
| Q4 24 | $395.7M | $23.0M | ||
| Q3 24 | $385.5M | $22.3M | ||
| Q2 24 | $389.1M | $20.3M | ||
| Q1 24 | $392.6M | $19.6M |
| Q4 25 | $461.5M | $84.0M | ||
| Q3 25 | $494.9M | $51.2M | ||
| Q2 25 | $493.3M | $52.7M | ||
| Q1 25 | $482.6M | $47.1M | ||
| Q4 24 | $499.5M | $47.9M | ||
| Q3 24 | $491.2M | $43.0M | ||
| Q2 24 | $483.7M | $47.2M | ||
| Q1 24 | $492.1M | $45.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $3.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $3.7M |
| FCF MarginFCF / Revenue | -2.9% | 7.8% |
| Capex IntensityCapex / Revenue | 1.6% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $3.9M | ||
| Q3 25 | $-3.9M | $-1.7M | ||
| Q2 25 | $108.0K | $6.0M | ||
| Q1 25 | $-125.0K | $-857.0K | ||
| Q4 24 | $2.0M | $4.8M | ||
| Q3 24 | $13.2M | $-2.4M | ||
| Q2 24 | $6.2M | $3.6M | ||
| Q1 24 | $4.0M | $6.7M |
| Q4 25 | $-1.8M | $3.7M | ||
| Q3 25 | $-4.6M | $-2.2M | ||
| Q2 25 | $-1.5M | $5.5M | ||
| Q1 25 | $-974.0K | $-930.0K | ||
| Q4 24 | $1.1M | $2.5M | ||
| Q3 24 | $12.2M | $-4.0M | ||
| Q2 24 | $5.2M | $2.5M | ||
| Q1 24 | $3.4M | $6.6M |
| Q4 25 | -2.9% | 7.8% | ||
| Q3 25 | -8.7% | -6.2% | ||
| Q2 25 | -3.2% | 15.5% | ||
| Q1 25 | -2.3% | -2.8% | ||
| Q4 24 | 1.9% | 8.0% | ||
| Q3 24 | 23.7% | -14.1% | ||
| Q2 24 | 11.0% | 8.4% | ||
| Q1 24 | 7.6% | 24.8% |
| Q4 25 | 1.6% | 0.4% | ||
| Q3 25 | 1.3% | 1.5% | ||
| Q2 25 | 3.5% | 1.5% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 7.2% | ||
| Q3 24 | 2.0% | 5.6% | ||
| Q2 24 | 2.3% | 3.8% | ||
| Q1 24 | 1.3% | 0.4% |
| Q4 25 | — | 7.16× | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | 0.21× | 11.71× | ||
| Q3 24 | 14.05× | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | — | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MAMA
Segment breakdown not available.
